Page 2 - குறியீட்டு மருந்துகள் வைத்திருத்தல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from குறியீட்டு மருந்துகள் வைத்திருத்தல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In குறியீட்டு மருந்துகள் வைத்திருத்தல் Today - Breaking & Trending Today

InDex Pharmaceuticals Holding AB (publ) publishes Annual Report for 2020

InDex Pharmaceuticals Holding AB (publ) publishes Annual Report for 2020
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Peter Zerhouni , Pr Index Pharmaceuticals Holding , Index Pharmaceuticals Holding , Kindex Pharmaceuticals , Index Pharmaceuticals Holding Ab Annual , Company Certified Adviser , Annual Report , Dex Pharmaceuticals , Immunomodulatory Sequences , Nasdaq First North Growth , குறியீட்டு மருந்துகள் வைத்திருத்தல் , குறியீட்டு மருந்துகள் , ஆண்டு அறிக்கை , டெக்ஸ் மருந்துகள் , நாஸ்டாக் முதல் வடக்கு வளர்ச்சி ,

InDex Pharmaceuticals gets patent for additional DIMS compounds granted in Europe

InDex Pharmaceuticals gets patent for additional DIMS compounds granted in Europe
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.

Peter Zerhouni , European Patent Office , Company Codes , Index Pharmaceuticals Holding , Kindex Pharmaceuticals , European Patent , Immunomodulatory Sequences , Dex Pharmaceuticals , Nasdaq First North Growth , Dex Pharmagets , ஐரோப்பிய காப்புரிமை அலுவலகம் , நிறுவனம் குறியீடுகள் , குறியீட்டு மருந்துகள் வைத்திருத்தல் , குறியீட்டு மருந்துகள் , ஐரோப்பிய காப்புரிமை , டெக்ஸ் மருந்துகள் , நாஸ்டாக் முதல் வடக்கு வளர்ச்சி ,

InDex Pharmaceuticals updates shareholders list

InDex Pharmaceuticals updates shareholders list
News provided by
Share this article
STOCKHOLM, March 12, 2021 /PRNewswire/
InDex Pharmaceuticals Holding AB (publ) today announced that the list of shareholders on the homepage has been updated with information as of February 26, 2021.
The 15 largest shareholders in InDex Pharmaceuticals Holding AB (publ) were as of February 26, 2021:

Publication
The information was submitted for publication through the agency of the contact person set out above at 13:45 CET on March 12, 2021.
InDex Pharmaceuticals in brief
InDex is a pharmaceutical development company focusing on immunological diseases where there is a high unmet medical need for new treatment options. The Company s lead asset is the drug candidate cobitolimod, which is in late stage clinical development for the treatment of moderate to severe ulcerative colitis - a ....

Staffan Rasj , Stiftelsen Industrifonden , Nordnet Pensionsf , Se Bankens Utvecklingsstiftelse , Peter Zerhouni , Life International , Prnewswire Index Pharmaceuticals Holding , Kindex Pharmaceuticals , Index Pharmaceuticals Holding , Company Certified Adviser , Avanza Pension , Dex Pharmaceuticals , Immunomodulatory Sequences , Nasdaq First North Growth , வாழ்க்கை சர்வதேச , குறியீட்டு மருந்துகள் , குறியீட்டு மருந்துகள் வைத்திருத்தல் , அவன்ச ஓய்வூதியம் , டெக்ஸ் மருந்துகள் , நாஸ்டாக் முதல் வடக்கு வளர்ச்சி ,

Ulcerative Colitis Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027

Ulcerative Colitis Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027
Published: Dec. 29, 2020 at 9:22 a.m. ET
The MarketWatch News Department was not involved in the creation of this content.
Dec 29, 2020 (Market Insight Reports)
The Global Ulcerative Colitis Market is estimated to register a CAGR of over 4.8% during the forecast period 2020 to 2027.
The research report titled Ulcerative Colitis offers comprehensive information on key driving factors, pricing analysis, market growth trends, brand positioning, competitive landscape, product usage and consumer psyche. This report provides an extensive analysis on market segmentation, strategies for prominent players and market overview. The market overview consists of important parameters extracted from different government bodies, industry and trade associations, information brokers, key companies and other such organizations. The insights obtained fr ....

United States , United Kingdom , South Korea , Boehringer Ingelheim Gmb , Sanofi Aventis , Asia Pacific , Eli Lilly , Market Analysts At Futurewise Research , Celgene Corporation , Merck Co , Takeda Pharmaceuticals , Pfizer Inc , Futurewise Market Research , Abbvie Inc , Salix Pharmaceuticals Inc , Bausch Health Companies Inc , Mitsubishi Tanabe Pharma Corporation , Research Methodology , Index Pharmaceuticals Holding , Company Profiles , Biolinerx Ltd , Ajinomoto Pharmaceuticals Co Ltd , Browse Related Healthcare Market Research , Abbott Laboratories , Avaxia Biologics Inc , Head Of Business Development ,

Ulcerative Colitis Market Research by Size, Top Leading Countries, Consumption, Drivers, Trends, For

Search jobs
24-Dec-2020
Ulcerative Colitis Market Research by Size, Top Leading Countries, Consumption, Drivers, Trends, Forces Analysis, Revenue, Challenges, Top Companies-Allergan, AbbVie, Bayer AG, UCB S.A
DBMR has launched a new market report titled
Global Ulcerative Colitis Market Size, Share, Industry Trends and Forecast to 2027 which is an output of a brief assessment and an all-inclusive analysis of the market’s key factors. The study covers details of market size, share, trends, growth spectrum, and the competitive scenario of the global Ulcerative Colitis market in the forecast timeline. The report has learned various factors like market growth, consumption volume, market trends, and business price structures throughout the forecast amount from 2020 to 2027. The report discovers general market scenarios and future market situations along with an analysis of market trends, current and future, drivers, chall ....

United States , Hong Kong , United Kingdom , Sanofi Aventis , Eli Lilly , Research Scope The Ulcerative Colitis , Allergan Inc , Takeda Pharmaceutical Company , Merck Co Inc , Peer Group Analysis , Pfizer Inc , Matrix Company Profile , Abbvie Inc , Johnson Services Inc , Route Of Administration Parentral , Manufacturing Technology Of Ulcerative Colitis , List Of Companies , Bayer Ag , Pvt Ltd , Index Pharmaceuticals Holding , Team Market Research , Accessa Complete Research Report , Market Research , Ulcerative Colitis Market Factor Analysis Porters Five , Company Profile , Perrigo Company ,